2026 NPPES data Dermatology Physician NPI 1972543098 M.D.
Verify on CMS →

MARC GROSSMAN, M.D.

Dermatology Physician in WHITE PLAINS, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
783
Medicare Part D claims · 244 beneficiaries · Dermatology Physician avg: 729
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]

What the federal data shows

MARC GROSSMAN, M.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 783 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
783
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARC GROSSMAN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARC GROSSMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARC GROSSMAN, M.D.?

Below national average

NPI registry status

Active

Issued 06/07/2006

NPI 1972543098

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

783 7% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in New York

How Dermatology Physician compares to other specialties among New York providers

New York providers

Dermatology Physician share within New York

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within New York

Medicare quality performance — MIPS

MARC GROSSMAN, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Dermatology Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARC GROSSMAN, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 12 GREENRIDGE AVE, WHITE PLAINS, NY, 10605, with a listed phone of (914) 946-1101. NPI 1972543098 was issued on 06/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GROSSMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 783 prescription claims written by this provider, covering 244 Medicare beneficiaries and totaling roughly $201K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12 GREENRIDGE AVE
WHITE PLAINS, NY 10605

Provider Details

NPI 1972543098
Specialty Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 06/07/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MARC GROSSMAN, M.D.. To verify MARC GROSSMAN, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

783
Total Claims
$201K
Total Drug Cost
244
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
948
Total Day Supply
23,625
Generic Drug Cost
$39K
Antibiotic Claims
44

Patient Demographics

Average Patient Age
79.5 years
Avg HCC Risk Score
1.24
Gender Split
50% female / 50% male
Age Distribution
<65: 0, 65-74: 73, 75-84: 111, 85+: 60

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARC GROSSMAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Triamcinolone Acetonide
69
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
44
Mometasone Furoate
42
Fluorouracil
39
Mupirocin
38
Ketoconazole
36
Betamethasone Dipropionate
35
Betamethasone Valerate
29
Clobetasol Propionate
26
Prednisone
21

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MARC GROSSMAN, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MARC GROSSMAN, M.D.'s 783 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GROSSMAN.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARC GROSSMAN, M.D.'s specialty?
MARC GROSSMAN, M.D. specializes in Dermatology Physician and practices in WHITE PLAINS, New York. Credentials: M.D..
How much does MARC GROSSMAN, M.D. prescribe under Medicare Part D?
In 2023, MARC GROSSMAN, M.D. wrote 783 Medicare Part D claims totaling $201K in drug costs for 244 beneficiaries.
What is MARC GROSSMAN, M.D.'s Medicare quality score?
MARC GROSSMAN, M.D. has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARC GROSSMAN, M.D. located?
MARC GROSSMAN, M.D. is located at 12 GREENRIDGE AVE, WHITE PLAINS, NY, 10605. Phone: (914) 946-1101.
What is MARC GROSSMAN, M.D.'s NPI number?
MARC GROSSMAN, M.D.'s National Provider Identifier (NPI) is 1972543098, issued on 06/07/2006.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MARC GROSSMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARC GROSSMAN, M.D.'s most frequently prescribed drugs include Triamcinolone Acetonide, Betamethasone Diprop Augmented, Mometasone Furoate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARC GROSSMAN, M.D. accept Medicare?
MARC GROSSMAN, M.D. appears in CMS Medicare data with 783 Part D claims and 244 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARC GROSSMAN, M.D.'s credentials?
MARC GROSSMAN, M.D.'s NPI is 1972543098 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology